Dyne Therapeutics, Inc. DYN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s enterprise value?
- Dyne Therapeutics, Inc. (DYN) reported enterprise value of $2.41B in Q1 2026.
- How has Dyne Therapeutics, Inc.'s enterprise value changed year-over-year?
- Dyne Therapeutics, Inc.'s enterprise value increased by 227.9% year-over-year, from $734.32M to $2.41B.
- What is the long-term trend for Dyne Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s enterprise value has grown at a 27.6% compound annual growth rate (CAGR), from $738.87M to $2.5B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.